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ABSTRACT 
Postoperative pam IS common following knee arthroscopy and 
has been typically controlled with opioids, the most popular of which 
is morphine. Morphine has been traditionally administered by 
intramuscular, intravenous, or epidural injections. These methods of 
administering morphine have been very effective in producing 
prolonged analgesia; however, they have also produce negative 
central nervous system side effects. 
Recent research has suggested administering morphine via 
intraarticular injections to provide postoperative analgesia without 
the central nervous system side effects. However, there is little 
evidence to suggest that this method is effective. Therefore, the 
purposes of this randomized, double-blinded study were to 1) 
investigate the effects of intraarticular injections of morphine on 
pain, 2) determine the minimal effective dose of morphine, and 
3) determine the effect of morphine on the need for supplemental 
analgesia (pain pills). 
Seventy-six subjects participated m the study and were 
randomly injected with 0.0 mg, .25 mg, .50 mg, .75 mg, or 1.00 mg of 
viii 
morphine. Pain was assessed at 1, 3, 6, and 24 hours postoperatively 
using a 100 mm visual analogue scale. Subject's requests for 
supplemental analgesia were also recorded. 
The results of this study found that any time interval > 5 hours 
resulted in a significant decrease in pain. The results of this study, 
however, did not find intraarticular injections of morphine to 




Knee arthroscopy is currently the most common orthopaedic 
surgical procedure in the United States; 1.2 million are performed 
each yearl. Forty-one percent of these patients report significant 
pain2, especially during the first twenty-four hours3 . Therefore, 
postoperative pain is an important issue for physical therapists. 
Pain affects patient comfort, discharge status, and overall 
rehabilitation potential. Studies have shown that severe pam IS 
difficult to treat3 and is frequently undermedicated3-5 . Considering 
the volume of arthroscopic procedures and the frequency of pain, 
effective analgesics must be found. 
Postoperative pain has been typically controlled with opioids, 
the most popular of which is morphine. Numerous studies have 
shown morphine to be very effective for pain, producing prolonged 
analgesia for 12 to 24 hours3 ,5-9 . Morphine accomplishes 
this by blocking transmission of pain impulses, inhibiting afferent 
pain pathways while sparing efferent motor and proprioceptive 
functions 7 . 
1 
2 
Opioid (or morphine) receptors are present at two sites7 : 
1) The presynaptic endings of afferent pain fibers, or 
2) The interneuronal level within the dorsal horn of the spinal 
cord. 
Currently, the most popular method of administering morphine is 
epidurally3,9. This method directly affects the opioid receptors at the 
interneuronal level in the spinal cord. This effectively inhibits pain 
throughout the central nervous system. 
Along with it's advantages, morphine has several drawbacks 
and some of them are severe (Table 1). Epidural and intravenous 
injections of morphine affect the central nervous system (CNS) and 
produce negative side effects5. Research has documented that 
morphine can produce nausea6,9-13, vomiting6,9-13, sedation6,8,10-13, 
delay in gastric emptying I1 -13 , anaphlaxis12, pruritis6,8-12, 14, urinary 
retention6,8-12,14, and even seizures 12,13. One study found that 
pruritis was prevalent in 5-10%, and urinary retention in 20-40% of 
all cases l4 . The most severe side effect of morphine however, is 
delayed respiratory depression which can occur up to twenty-four 
hours later6, 8-15. Delayed respiratory depression has been 
documented in 4-7% of all cases l4 , and is especially dangerous to 
patients with short hospital stays. 
3 
TABLE 1 








Delay in Gastric Emptying 
Anaphlaxis 
Seizures 
a Study by Gustafsson et aI14 
b Study by Sabbe et al ll 
Prevalence 
4%-7%a 
5%-lO%a 8.5%b 46%c 
20%-40%a 
C Prevalence when administered intrathecally. Study by Sabbe et 
all 1 
4 
Recent research has explored alternative ways to administer 
morphine without these undesirable eNS effects 16. Opioid receptors 
outside of the eNS (or outside of the interneuronal level within the 
spinal cord) were sought out. Researchers have investigated opioid 
receptors that would provide localized pain relief without the side 
effects caused by affecting the central nervous system. 
Interest began with a study by Stein et al17 which implied that 
"peripheral sites" of tissue could contain opioid receptors for 
morphine. Stein found peripheral opioid receptors in the hind paws 
of rats, and morphine injected into inflamed areas produced 
analgesia. 
Further research by Stein and associates 18 found similar results 
III humans. Stein found evidence of opioid receptors in the knee 
joint, and demonstrated effective postoperative analgesia with 
intraarticular injections of morphine. Stein also found that 
intraarticular injections of morphine gave significantly greater pam 
relief than intravenous injections, and decreased the need for 
supplemental analgesia (pain pills) 18. The maximal effect was 3-6 
hours after injection 18. Furthermore, intraarticular injections of 
morphine were found to be safe, with none of the negative eNS side 
effects seen with epidural or intravenous morphine. Stein cited two 
5 
reasons for the lack of CNS side effects. First, pam was being blocked 
in the knee joint (i.e. at the presynaptic level) as opposed to the · 
spinal cord level. Second, the low lipid solubility of morphine 
provided slow uptake out of the knee joint18,19. Both of these factors 
reduced the CNS concentration of morphine providing pain relief 
without the side effects. Additional research done by Khoury et apo, 
and Joshi et aPO,21 supported Stein and found intraarticular 
morphine to significantly reduce pain without any side effects. 
Contrasting studies performed by Raja et aP3, Ruwe et aI24, and 
Heard et aP5 contradicted these results, finding no improvement in 
pain relief with intraarticular morphine. A study by Raja et aI23, 
found morphine to have no significant analgesic effect during the 
first two hours after surgery, similar to the observations reported by 
Stein 18 . However, Raja failed to demonstrate any delayed analgesic 
effect of morphine. Ruwe et aP4, also reported that morphine was 
not beneficial for postoperative pain, even in combination with other 
opioids. Finally, Heard et aI25 failed to find a significant benefit of 
morphine, even in larger volumes than used by Stein 18. 
Other research has indicated another opioid, bupivacaine, 
which may have a positive impact on pain when injected in the knee 
joint. Bupivacaine is an opioid that has been used to provide local, 
6 
surgical anesthesia lasting up to eight hours26. Numerous studies 
have found it to be safe, staying below toxic levels even with 100 mg 
injections23 ,25-29. Bupivacaine also does not damage articular 
cartilage30 . Recently, studies20,23,25,31,32 have found bupivacaine to 
be effective in providing post-operative pain relief when injected 
into the knee joint. Khoury et apo found that bupivacaine produced 
immediate, short-term pain relief. Raja et aP3 also found it to be 
effective for a short period of time (two hours). Research by Heard 
et aP5, Chirwa et aP 1, and Smith et aP2 all reported both short-term 
and prolonged pain relief through bupivacaine. However, other 
studies2,22,24,26 conflicted with these findings, and failed to show any 
beneficial effect. Research by Khoury et apo, and Joshi et aP2 
reported conflicting results on the effectiveness of bupivacaine; but 
both studies compared bupivacaine to morphine and found morphine 
to be more effective in relieving postoperative pam. Additional 
research on bupivacaine is needed, but for the purposes of this 
study; only the effect of morphine on pain relief was investigated. 
Postoperative pain relief is an important issue, and the results 
of past studies are varied. Further research is needed to determine 
if intraarticular morphine is or is not an effective method of 
controlling postoperative pain. The purpose of this randomized, 
7 
double-blinded study was to compare morphine to a placebo injected 
into the knee after arthroscopic surgery. This study sought to 
determine if intraarticular morphine was an effective treatment for 
postoperative pain and if so, determine the minimal effective dose. 
The effect of intraarticular morphine on the need for supplemental 




The study protocol was approved by the United Hospital 
(Grand Forks, ND) institutional research committee, prior to 
beginning the study (See Appendix A). Seventy-six subjects (fifty 
males and twenty-six females) between the ages of 15-55 
participated in this study. Each patient underwent elective 
outpatient arthroscopic knee surgery performed by a single surgeon 
(Dr. Brian T. Briggs) at Grand Forks United Hospital. The surgical 
procedures included partial menisectomies, plicectomies, and · 
grade(s) 1,2,3 chondromalacia. Patients were excluded from the 
study for the following reasons: an allergy or sensitivity to morphine, 
not completing all the necessary questionnaires, or undergoing 
procedures for grade 4 chondromalacia, lateral retinacular release, or 
osteochondritis dessicans. 
Study Design 
Preoperatively, all patients were educated with regard to 
postoperative pain measurements and the use of the Visual Analogue 
8 
9 
Scale (V AS). General anesthesia was used in all cases, and no 
narcotics were administered intraoperatively. A tourniquet was 
applied ten minutes before the incision was made, and removed after 
the procedure, an average of 25-30 minutes later. At the conclusion 
of the surgery, a double-blinded procedure was used to randomly 
inject the patient with one of five solutions. A placebo or a solution 
containing morphine was injected directly into the knee joint. Group 
1 (N=15) received an injection of 10 cc's normal saline. Group 2 
(N=15) received 10 cc's of normal saline and 0.25 mg morphine. 
Group 3 (N=14) received 10 cc's of normal saline and 0.50 mg 
morphine. Group 4 (N=19) received 10 cc's of normal saline and 0.75 
mg morphine. Group 5 (N=13) received 10 cc's of normal saline and 
1.00 mg morphine. The injections were prepared by a pharmacist, 
randomized, and were revealed only at the completion of the study. 
The operating physician, the nursing staff, nor the patient were 
aware of the dosage. 
Pain assessment 
Postoperative pam was assessed with a 100-mm Visual 
Analogue Scale (VAS). Studies have shown the VAS to be simple33 -
36 reliable33 ,37 valid33 -39 and the most sensitive33 ,36-38 measure of , , , 
pam. The scale ranged from no pain (0 mm), to excruciating or 
unbearable pain (100 mm) (Fig. 1). Subjects were asked to place 
10 
a vertical line on the scale to mark the pain they were feeling at that 
moment. V AS scores were recorded at 1, 3, 6, and 24 hours post-
operatively. In addition, supplemental analgesia of Darvocet #100 
and Tylenol #3 were made available to the patients and their use 
was documented. 
Statistical analysis 
The V AS score was obtained by measuring the distance in 
millimeters from zero (no pain) to the mark made by the patient. 
These measurements were taken by the same person to ensure 
consistent, reliable results. Comparisons of pain scores from the V AS 
and the need for supplemental analgesia were made using the Abstat 
Version 1.8 computer software (Anderson-Bell Corporation, Arvada, 
Co 80006). A two-way analysis of variance with repeated measures 
was used to analyze the relationship between morphine and pain. A 
one-way analysis of variance was used to compare the need for 
supplemental analgesia and pain. 
A p value of < .05 was considered to be statistically significant. 
NO PAIN I IEXCRUCIATING 0 
UNBEARABLE PAIN 





One hundred patients received intraarticular injections, and 
seventy-six were included in this study. The other twenty-four 
patients were excluded due to incomplete questionnaires. There 
were no significant differences among the groups in regards to 
gender or type of surgical procedure. 
There was a significant decrease m pain (i.e. lower VAS scores) 
within all groups over the twenty-four hour time period (Table 2) 
(Figure 2). Scheffe and Tukey post hoc tests found that any time 
interval > 5 hours resulted in significant decreases in pain. This held 
true for all groups regardless of morphine dose or number of pain 
pills taken. There were no significant differences between any of the 
five groups at any of the time intervals (1, 3, 6, or 24 hours post-
operatively) (Table 2). 
The most significant finding of this study was that 
intraarticular morphine injections did not significantly decrease V AS 
pam scores. A two-way ANOVA with replications indicated that 
there were no significant differences in pain between the control 




Two Factor (Morphine Dose x Time) Analysis of Variance 


























47.1398 19.0772b .0000 
1.1583 .4688 .9313 
2.4710 
a Time of recording VAS score (VAS at 1, 3, 6, 24 hours) 
b Significant at p < .05 
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0.0 MG 
• . 25 MG 
• . 50MG 
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Figure 2. Visual analogue scale score (in mm's) over time for eact1 treatment 
group; significant at p <.00001. 
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which had received morphine (Table 2). This table illustrates the 
variability of VAS results between each group. Figure 3 shows the 
visual analogue scores for each treatment group. Interestingly, while 
not significant, the control group (0.0 mg morphine) demonstrated 
the lowest VAS at 1,3,6, and 24 hours. 
The presence or absence of morphine also did not have a 
significant impact on patient's requests for analgesics. Descriptive 
statistics on the amount of supplemental analgesics taken and the 
V AS for each treatment group are shown on Table 3. The number of 
pain pills taken was consistent across all five treatment groups 
(Figure 4). 
5. . ............................................... ..... ............ . _ ............. _._ ............................ ..... . _ ..................... _ ......... ....... .............. . , . .•••••.•••••••••.. · ...... ··· •••• · ••• · ........ ······.·.·H.·· .. ·"_ 1110.0 MG 
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Results of Visual Analogue Scores (VAS) and Need for 
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The results of this study found that intraarticular injections of 
morphine had no significant effect on postoperative pain or need for 
supplemental analgesia. These results support similar findings by 
Raja et aI23, Ruwe et aI24, and Heard et aps. 
The results were m disagreement with those reported by Stein 
et aIl8, Khoury et apo, and Joshi et aP2. Stein et aIl8 reported a 
significant reduction in pain with morphine; however, this effect was 
only at a single point in time (3 hours after injection). Additionally, 
Stein and associates 18 did not report on patients in the control group 
of their study. The study performed by Khoury et apo did not 
include a control or placebo group, and the results may have also 
been biased by the subject size (N=7). Results reported by Joshi et 
aI22 were also compiled from a limited number of subjects (N=20). 
There are other possible explanations for discrepancies with 
these studies. Joshi et aP2 used a significantly higher dose of 
morphine (5 mg) when compared to the highest dose used in this 
study (1 mg). It is possible that higher doses of morphine will elicit 
19 
20 
the desired analgesic effects . Also, in the study by Stein et all 8 , 
patients received a larger volume of intraarticular injection (40 ml). 
This could have contributed significantly to the absorption of 
morphine and relief of pain. 
This study may also have included other factors which affected 
the outcome. Pre-surgical pain scores were not obtained in this 
study. This is important as pain is a combination of both 
physiological and psychological factors 37 . In fact, in studies by Ruwe 
et aP4 and Henderson et aP6, pre-surgical pam scores were found to 
be the most significant indicator of post-surgical pain. 
Another factor which may have affected the outcome was the 
variable length of tourniquet inflation. Studies by Joshi et al40 and 
Katz et al41 have reported that the tourniquet should be inflated a 
minimum of ten minutes after injection. This facilitates local tissue 
binding in the knee joint and increases the effect of morphine. In 
this study, the tourniquet was in place an average of 25-30 minutes 
total. However, the amount of time it was in place after injection was 
variable, which may have influenced the results. 
This study also used general anesthesia as opposed to regional 
anesthesia. This could have been an additional factor as research by 
Heard and associates25 found significantly lower (p < .05) VAS scores 
21 
III patients who underwent regional anesthesia, regardless of post-
operative pain treatments. 
Finally, the method of pain interpretation or VAS also had it's 
limitations. Numerous authors34,36-39,42 have stated that the VAS 
has two deficiencies; a source of error introduced with measurement 
of the patient's slash mark, and the effect of age on validity. 
Research by Kremer et al42 found a significant correlation between 
the patient's age and incorrect responses. Another author38 stated 
that the VAS "not be employed as a primary measure of pain 
intensity in adult clinical populations". These findings and opinions 
certainly applied to this study as the patient population age was 15-
55. However, I believe the benefits, reliability, and validity of the 
VAS far outweigh these proposed drawbacks. 
CHAPTERS 
CONCLUSION 
The results of this study suggest that morphine injections into 
the knee joint after arthroscopic surgery do not significantly reduce 
pain. However, further research IS needed. Additional studies are 
needed to address both the dosage and volume of morphine 
injections, psychological factors such as preoperative pain scores, 
tourniquet release time, mode of anesthesia, and alternative opioids 
such as bupivacaine. Additional research should also be performed 
following surgical procedures other than arthroscopy, as pain is a 
prevalent problem. For example, it has been reported that 75% of all 
TKA's (total knee arthroplasties) have significant pain despite 
supplemental analgesics43 . 
Comprehensive, double-blinded studies addressing these 
variables and areas for research would solidify previous conflicting 
results and add to the knowledge base. This would be a benefit to 
physicians, clinicians, and patients alike. 
22 
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\ ' !, ' Ti l i,' dpse will hc identified which provides optimum pain relief with few side effects. 
" \ ;Z 1 i : II "'~'rIS 
' i 'n ldi" idu:ds hetween thc ages of 15-60 (malc and female), who are not allergic or sensitive to morphine and who have heen 
' ,, ' , 'Ill :' !<" Hled to undergo knee arthroscopy to help treat their knee condition, will be invited to {>articipate. Refusal by thc pntient 
: ' ,L,;I!. il':ll c in the study will in no way affect , the quality of orthopedic care they receive. Participants will receive no 
" ' \i ! q" ' ! h , tl i(l" for their pnrticipation_ 
... , ;, '" I I !!! !' (',,(,lanation of the study will be provided by Dr. Briggs prior to surgery, and the patient will be asked to read and sign 
: " , ''' '· , ' ll l I" rm (cnclosed). 
, !< ( " I 1)1 : gL~ 
. 'o il " !I , " ,'! ; "~; will be performed at the United Hospital by Dr. Brian T. Briggs, Orthopedic Surgeon. Postoperative assessment s 
, ili :, 'l !l,kl' the direction of Lori Klabunde, Nurse Practitioner. All patlents will be educated about the postoperative pain 
" " , ', \1 1 \ I l1 l'nt ~ and the use of the Visual Analogue Scale prior to surgery (enclosed). 
i ',l .i , :!I" "': ill he randomized into one of five groups as follows: 
i'!Ha ;lrtieuiar injection of 10 cc's normal saline 
j"'I<larticular in~ection of 10 cc's normal saline + 0.25 mg. morphine 
;"tr;wrtil.'ular in~edion of 10 cc's normal saline + 0,50 mg. morphine 
;'ll:aartil.'ular in~ection of 10 cc's normal saline + 0.75 mg. morphine 
III ! I :l:lIt icular injection of 10 cc's normal saline + 1.00 mg. morphine 
: ' :::to: · 1 , I, 'nl'k-hlinued system, once arthroscopy is completed, each patient will be injected with one of the above solutions, The 
p ,1 10 III 'odl ht' asked to complete the Visual Analogue Scale at 1 hour postol'eratively, 2 hours postoperatively, 3 hours 
," " " 'j" ,! .li '.l f:ly and 6 hours postoperatively, They.will also be sent home witli a scale to fill out approximatefyi4 hours after the 
' t: i ' :,,' ; \ ' I bl'se scales are completed by simply 'placing a vertical line on a scale to mark the dewee of pain they're experiencin~ 
: " i ' !l i: nt \\'ill he given supplemental analgeSia as it is required in the form of intramuscular mjections and/or oral agents . ;\11 
" " I ' ; : \ " :!I~' I1I, al :ll1algesicswilrlle documenteoand used in the evaluation process. 
'. 1 .. , philH' j , :I Schedule II narcotic medication commonly used to relieve pain. When administered intramuscularly, intravenously, 
" . h- !,\, "'tlt, the standard recommended dose is between 10-20 m~. every 4-6 hours. Given by the above mentioned roult's, 
d . , rr' ,i ;'" ;ll't -; upon the central nervous systcm to produce pain rehef without loss of sensation or consciousness. Morphine i~ 
., , ! , h ;1" "('pt ed hy the .... );\ and has been used for many years. 
, " . ' ;;: '1 '.ide dfects of morphine include respiratory depression, nausea and vomiting, itching, urinary retention, and a sense \If 
: ,; , j " , ( : ! , ;\n allergic reaction to morphine may also occur in those not aware of a previous allergy. 
: j , ; !." ,!i :llion will be prepared in the United Hospital Pharmacy under the direction of Dr. Bill Reay, Pharmacy Director 
:!" ' ' .1 : ' : ' \ i a Is will he randomized and sent to surgery prior to each arthroscopy. 
, " ' i! ' '0 ' dl he closely monitored by specially trained nurses postoperatively for side effects. Medications will be availahle to heir 
" j , id l' dkcts, . ' :,1 
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( ;f i f T 11"; : (DescrIbe the benefIts to the Indlvlcllal or ~Iety.) 
i " , ' , ;, ' " . ,' : ll'lhJ'(1~r(lpic ~ arc rerformed on an outpatient basis, pain is present postoperatively which requires some f<'1'1ll " I 
', ; IIl('rli,':rli"I1 , Morrhine is a very effective medication used to control pain. The side effects of morphine arc causcd b\ 
, " :, ,, I hI ' l'cnlrnl nervOlls system. By directly injecting morphine into the joint, the central nervous system is not affl'c\I'll 
, ;' i' I h,: ,ide effects arc reduced. Research has proven that there are special receptors present within the joint that wil 
.,; : I I : ':t I 1\ I1wdirat ion when injected and, therefore, relieve pain. 
: ' "i : , , '""Ii,.'s have also rroven that low dose morphine injected into the joint provides safe, effective pain relief devoid Ilf ,ili l 
, " , : , I !.,'I';lIl<;e pnt ients ret urn home so quickly after surgery (often within 4-6 hours), it is imperative that adequate pain wnt rc I 
, : ' : " 'f' II ,. I1t'd, and helrful if this can be done with few side effects. 
! , r.! ~¥.s: (Oeser lbe the risks to the SJbJect and preccut lens that will be taken to minimize thEm The o:ncept 
of risk g:)eS be)'a1d phYSical risk and InclUdes risks to the subject's dlgllty am self r t 
~I I as psycrolog lcaI • erotlc:nal or behaVioral risk. If data are (X)llected Ytfllch COlI~o:e as 
h;mnful or robarrasslng to the 9JbJect If a~lated with him or her, then describe the rre~ to 
be used to Insure the cx:nfldentlallty of data obtained, Including plans for final dlsposltl 
destruct len, debr lef Ing proced..lres, etc.) ' en or 
! iii ;'n! " lIli " l side effects of morphine are well-documented when it is given by traditional routes. These include resrirator) 
,: , p: " .. ,'·i· '11. nausea and vomiting, Itching, somnolence, and an allergic reaction. ' " 
, 'f' b I ,, "!: nt is closely monitored by specially trained professionals after surgery. Vital signs are measured every 15-30 minutl'~ 
':\- i ,', ,( !J patient is carefully assessed for any complications. Medications may be given to help control side effects. 
\'; r ,d ; ' ,; \ fiks anLl hospital records will be kept confidential. Once completed, files containing study information will be kepi 
,' , , ' , ·,di dt'lltiai filc hy Lori Klabunde at the Grand Forks Clinic. , 
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' . : ' ; 1;1 r 'jJA : A c:cpy of the CXl£t:NT RnA to be slg"led by the &.Jbjeet (If applicable) and/or any statarcnt 
to be read to the &.Jbject !tnlld ~ attached to this form. If ro aN59lT RR.4 Is to be u~ . 
dxl..rrmt the procedJres to be used to aS9.lre that Infr Irgerrent upcn the subject's rights will 
rot ocrur. 
Des::r lbe v.nere slg"led cx::nsent forms will be kept and for \'tt1at period of tlrre. 
,', 't m .L IOC R£VIEW forward a sl~ or Iglnal and 12 cx::ples of this cx:rrpleted form and, v.nere applicable, 12 
';.''{ ? ~ '::5 o f the prq:x:lSed cx:nsent form, QJeStlcrnalres, etc., and any support Ing cbctrrentatlcn to: 
r I (>~'1ror Tve I t 
1i)~ Sxl t h Cb I LJTb I a Road 
Cr am Forks. W 58201 
;" . ~ rxFWT or EXPEDITED R£VIEW forward a slgred original and a cx::py of the ccnsent form, Q.lestlcrnalres, 
"! t c . , <"lnd any ~t1ng d:::x:::t.Jmntatlc:n to the address aOOve. 
:'., : (' 1 ! " : ! ~5 am proced.lres 01 Use of I-t.nan SJbJects In ~Ical Park Instltutlc:ns awly to all activities 
' : · ... ·· hh;:J w:"'" of H..rran SJbjects perfOf'1reCl by perscrnel cxn:ltctlng such activities. N::> activities are to be 
j 'l ;~ !;)!~v J v;lttnlt prior review and awroval of' the ~Ical Park Instltutlc:nal RevleN O:mnlttee. 
. " -..... _ ---------------- DATE: ____________ __ 
PI' Inc lpa I Investigator 
DATE: ____________ __ 
f'r:::> JlXt Director 
DATE : ___________ _ 
':: lucrnt Adviser (v.nere applicable) 
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INFORMATION AND CONSENT FORM 
The Effect of Intra-articular Morphine on Post-arthroscopy Pain 
You are being invited to participate in a study being conducted by Dr. Brian Briggs and 
his staff regarding the use of morphine to control postoperative pain. One goal of this 
study is to determine if an injection of morphine directly into the knee joint following 
your arthroscopic surgery will affect the amount of postoperative pain you experience. 
The other goal is to determine a proper dosage for the morphine injection. Only subjects 
who were normal and healthy prior to their knee problem will be included in this study. 
Prior to your surgery you will be given instructions on the pain testing procedures that 
will be done after surgery. For the testing, you will be asked to rate your pain on a scale 
which varies from a response of "no pain" to "unbearable pain". In addition an examiner 
will ask you to bend your knee, and then that examiner will measure the distance you 
moved your knee. These same measurements will be conducted at 1, 3 and 6 hours after 
your surgery. In addition, you will be asked to fill out a short questionnaire after 24 
hours at home. You will be instructed on how to fill out the questionnaire. 
As a participant in this study you will be randomly assigned to one of five (5) treatment 
groups. Four of those groups will be given different dosage levels of morphine, and the 
other group will be given a placebo injection. It is not clear at the present time which of 
the treatment programs would be better for you. For this reason, the treatment plan which 
is offered to will be based upon a method of randomization. Randomization means selec-
tion of a treatment by chance. This is predetermined by the doctor's staff, and selection of 
treatment for each patient is done in a sequential manner. This is equivalent to flipping a 
coin to select one of two treatments. 
The actual testing procedure will only take approximately 5 to 10 minutes of your time. 
The testing procedure should not cause you any discomfort or inconvenience over and 
above the standard post-operative procedures. 
As with the administration of any medication, there are some risks involved with the ad-
ministration of morphine. Although the dosages of the drug used are well within normal 
clinical guidelines, the use of morphine does carry some risk. Because morphine is used 
on a routine basis, we do not anticipate any problems. However, potential risks may in-
clude respiratory depression (i.e. difficulty breathing), allergic reaction, nausea, vomiting, 
itching and drowsiness. While you are in the hospital following your surgery, you will be 
under the direct care of the hospital physician and nursing staff to monitor your progress 
and intervene should you experience any problems. 
The benefits to you as a participant include enhanced control of post-operative pain with-
out the standard repeated drug injections which can increase the side effects of the pain 
medication. A more effective means of controlling pain will ultimately lead to decreased 
post-operative pain, better joint movement and less weakness. 
Any information that is obtained in connection with the study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. The 
data collected will be identified by a number known only by the investigators. You will 
not be assessed any additional cost as a study participant. 
Your decision whether or not to participate in this study will not prejudice your future 
relationship with your doctor or with the United Hospital staff. If you decide to partici-
pate, you are free to discontinue participation at any time without prejudice. 
The investigators involved are available to answer any questions you have concerning 
this program. In addition, you are encouraged to ask any questions concerning this pro-
gram that you may have in the future. Questions may be asked by calling Lori Klabunde 
at 780-6112. A copy of this consent is available to participants in this study. 
In the event that this research activity results in a physical injury, and the project is being 
conducted in a health care facility, medical treatment will be available, including first aid, 
emergency treatment, and follow up care as needed. Payment for any such treatment 
must be provided by you and your third party payor, if any. 
"ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED 
TO ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING THIS STUDY IN 
THE FUTURE." 
I have read all of the above and willingly agree to participate in this study explained to 
meby __________________________ _ 
Patient's Signature Date 
Witness (not the investigator) Date 
Parent or Legal Guardian's Date 
Signature 
I have explained fully to the patient the above objective of this study, what is to be 
expected, and the possible complications. 
Counseling Physician's Signature Date 
REFERENCES 
1. Shapiro MS, Safran MR, Crockett H, Finerman G. Local anesthesia 
for knee arthroscopy: Efficacy and Cost Benefits. Am J Sports 
Med. 1995:23:50-53. 
2. Milligan KA, Mowbray MJ, Mulrooney L, Standen PJ. Intra-
articular bupivacaine for pain relief after arthroscopic surgery 
of the knee joint in daycase patients. Anesthesia. 
1988:43 ;563-564. 
3. Drakeford MK, Pettine KA, Brookeshire L, Ebert F. Spinal 
narcotics for postoperative analgesia in total joint arthroplasty. 
J Bone Joint Surg. 1991:73(3);424-428. 
4. Kleiman RL, Lipman AG, Bradford DH, MacDonald SD. A 
comparison of morphine administered by patient-controlled 
analgesia and regularly scheduled intramuscular injection III 
severe, postoperative pain. J Pain Symptom Manage. 
1988:3(1);15-22. 
5. Edwards WT. Optimizing opioid treatment of postoperative 
pain. J Pain Symptom Manage. 1990:5(1);24-36. 
6. Mahoney OM, Noble PC, Davidson J, Tullos HS. The effect of 
continuous epidural analgesia on postoperative pain, 
rehabilitation, and duration of hospitalization in total knee 
arthroplasty. Clin Orthop. 1990;260;31-37. 
7. Lipp J. Possible mechanisms of morphine analgesia. Clin 
Neuropharmacol. 1991: 14(2); 131-147. 
8. Finley RS. Pain management with spinally administered 
opioids. Am J Hosp Pharm. 1990:47;14-17. 
30 
31 
9. Ready LB . Spinal opioids in the management of acute and 
postoperative pain. J Pain Symptom Manage. 
1990:5(3);138-145. 
10. Brown CR, Moodie JE, Wild VM, Bynum LJ. Comparison of 
intravenous ketorolac tromethamine and morphine sulfate III 
the treatment of postoperative pain. Pharmacotherapy. 
1990:10;116-121. 
11. Sabbe MB, Yaksh TL. Pharmacology of spinal opioids. J Pain 
Symptom Manage. 1990:5(3);191-203. 
12. Walsh TD. Prevention of opioid side effects. J Pain Symptom 
Manage. 1990:5(6);362-367. 
13. Yaster M, Deshpande JK. Management of pediatric pain with 
opioid analgesics. J Pediatr. 1988:113(3);421-429. 
14. Gustafsson LL, Zsuzsanna WHo Spinal opioid analgesia: a critical 
update. Drugs. 1988:35(6);597-603. 
15. Nielsen PT, Blom H, Nielsen SE. Less pain with epidural 
morphine after knee arthroplasty. Orthop Scand. 
1989:60( 4 );44 7 -448. 
16. Stanley TH. New routes of administration and new delivery 
systems of anesthetics. Anesthesiology 1988;68:665-668. 
17. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral 
opioid receptors mediating antinociception in inflammation. 
evidence for involvement of Mu, Delta, and Kappa receptors . J 
Pharmacol Exp Ther. 1989:248(30;1269-1275. 
18. Stein C, Comisel K, Haimerl E, et al. Analgesic effect of 
intraarticular morphine after arthroscopic knee surgery. N 
Engl J Med. 1991:325;1123-6. 
32 
19. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: 
Gilman AG, Goodman LS, RaIl TW, Murad F, eds. The 
Pharmacological Basis of Therapeutics. 7th ed. New York: 
Macmillan, 1985: 491-531. 
20. Khoury GF, Stein C, Garland DE. Intra-articular morphine for 
pain after knee arthroscopy. Lancet. 1990:336:874. 
21. Joshi GP, McCarroll SM, Cooney CM, et al. Intra-articular 
morphine for pain relief after knee arthroscopy. J Bone Joint 
Surg. 1992:74;749-751. 
22. Joshi GP, McCarroll SM, O'Brien TM, Lenane P. Intraarticular 
analgesia following knee arthroscopy. Anesth Analg. 
1993:76;333-6. 
23. Raja SN, Dickstein RE, Johnson CA. Comparison of postoperative 
analgesic effects of intraarticular bupivacaine and morphine 
following arthroscopic knee surgery. Anesthesiology. 
1992:77(6); 1143-7. 
24. Ruwe PA, Klein I, Shields CL. The effect of intraarticular 
injection of morphine and bupivacaine on postarthroscopic paIn 
control. Am J Sports Med. 1995:23(1);59-63. 
25. Heard SO, Edwards WT, Ferrare D, et al. Analgesic effect of 
intraarticular bupivacaine or morphine after arthroscopic knee 
surgery: a randomized, prospective, double-blind study. Anesth 
Analg. 1992:74;822-6. 
26. Henderson RC, Campion ER, DeMasi RA, Taft TN. Postarthroscopy 
analgesia with bupivacaine: a prospective randomized, blinded 
evaluation. Am J Sports Med. 1990;18(6):614-617. 
27. Gerber H, Censier K, Gachter A, et al. Intra-articular absorption 
of bupivacaine during arthroscopy-comparison of 0.25%, 0.5%, 
and 0.75% solution. Anesthesiology. 1985;63:217. 
33 
28. Meinig RP, Holtgrewe JL, Wiedel JD, et al. Plasma bupivacaine 
levels following single dose intraarticular instillation for 
arthroscopy. Am J Sports Med. 1988;16:295-300. 
29. Y oshiya S. Kurosake M, Hirohata K, et al. Knee arthroscopy using 
local anesthetic. Arthroscopy. 1988;4:86-9. 
30. Nole R, Munson NML, Fulkerson JP. Bupivacaine and saline 
effects on articular cartilage. Arthroscopy. 1985; 1: 123-7. 
31. Chirwa SS, MacLeod BA, Day B. Intraarticular bupivacaine 
(marcaine) after arthroscopic menisectomy: a randomized 
double-blind controlled study. Arthroscopy. 1989;5:33-5. 
32. Smith I, Shibely R, White PF. Effects of local anesthetic recovery 
after outpatient arthroscopy. Anesth Analg. 1991;73(5):536-9. 
33. Lee KA, Kieckhefer GM. Measuring human responses using 
visual analouge scales. West J Nurs Res. 1989:11(1);128-132. 
34. Lipman JJ. Pain measurement. In: Parris WCV, ed. 
Contemporary Issues In Chronic Pain Management. Boston, MA: 
Kluwer Academic Publishers;1991:123-146. 
35. Whittaker O. Pain measurement. In: Wardield CA, ed. Manual 
of Pain Management. Philadelphia, PA: J.B. LIppincott Company: 
20-23. 
36. Jensen MP, Karoly P, Braver S. The measurement of clinical pain 
intensity: a comparison of six methods. Pain. 1986:27;117-126. 
37. Eggebrecht DB, Bautz MT, Brenig MI, Pfingsten MP, Franz C. 
Psychometric evaluation. In: Carnic PM, Brown FD, ed. 
Assessing Chronic Pain: A Multidisciplinary Clinic Handbook. 
New York, NY: Springer-Verlag Company: 71-90. 
34 
38. Karoly P, Jensen MP. Measures of the subjective pain 
experience. In: Goldstein AP, Krasner L, Garfield SL, ed. 
Multimethod Assessment of Chronic Pain. New York, NY: 
Pergamon Press;45-46. 
39. Murrin KR, Rosen M. Pain measurement. In: Smith G, 
Covino BG, ed. Acute Pain. Boston, MA: Butterworths;116-118. 
40. Joshi GP, McCarroll SM, Cooney CM, et al. Intra-articular 
morphine for pain relief after knee arthroscopy. J Bone Joint 
Surg (Br). 1992;74(8):749-51. 
41. Katz JA, Kaeding CS, Hill JR, Henthorn TK. The pharmacokinectics 
of bupivacaine when injected intra-articularly after knee 
arthroscopy. Anesth Analg. 1988;67:872-5 . 
42. Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: patient 
preference does not confound pain measurement. Pain. 
1981;10:241-8. 
43. Nielsen PT, Rechnagel K, Nielsen SE. No effect of continuous 
passIve motion after arthroplasty of the knee. Acta Orthop 
Scand 1988;59(5):580-1. 
